A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus

Human carcinoma A431 cells were subcutaneously injected into nude mice at points remote from each other. One of the two xenografts developed after­wards was used for treatment with a recombinant vaccinia virus, while another served as an artificial metastasis. We used the attenuated recombinant vacc...

Full description

Saved in:
Bibliographic Details
Main Authors: G. V. Kochneva, A. A. Grazhdantseva, G. F. Sivolobova, A. V. Tkacheva, A. N. Shvalov, A. Yu. Unusova, E. I. Ryabchikova, S. V. Netesov
Format: Article
Language:English
Published: Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2015-12-01
Series:Вавиловский журнал генетики и селекции
Subjects:
Online Access:https://vavilov.elpub.ru/jour/article/view/439
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575215318597632
author G. V. Kochneva
A. A. Grazhdantseva
G. F. Sivolobova
A. V. Tkacheva
A. N. Shvalov
A. Yu. Unusova
E. I. Ryabchikova
S. V. Netesov
author_facet G. V. Kochneva
A. A. Grazhdantseva
G. F. Sivolobova
A. V. Tkacheva
A. N. Shvalov
A. Yu. Unusova
E. I. Ryabchikova
S. V. Netesov
author_sort G. V. Kochneva
collection DOAJ
description Human carcinoma A431 cells were subcutaneously injected into nude mice at points remote from each other. One of the two xenografts developed after­wards was used for treatment with a recombinant vaccinia virus, while another served as an artificial metastasis. We used the attenuated recombinant vaccinia virus (VACV) VVdGF-GFP2 of the L-IVP strain (GenBank accession number KP233807), with deletion of two virulence genes: the virus growth factor and thymidine kinase, with the gene for the green fluorescent protein (GFP2) inserted in an area of the latter. Treatments were performed by a single intratumoral injection of the recombinant VACV at a dose of 107 PFU/mouse. VACV was detected in cells of the artificial metastasis as early as two days following infection, and after 8 days virus concentrations were com- parable with those in the infected tumor (~109 PFU/ml). Electron microscopy revealed selective replication of the recombinant in tumor cells. Targeted accumulation of GFP2 in both tumor and metastasis was shown in the UV-images of the mice obtained using the In-vivo Multispectral Imaging System (Bruker, Germany). Complete destruction of the tumor was registered after 12 days, and that of metastasis, after 20 days post injection of VVdGF-GFP2. The destruction process was accompanied by pronounced edema and leukocyte infiltration of tumor tissue. The recombinant virus induced a significant reduction in the sizes of the tumor and metastasis: by the end of the experiment (35 days) the xenografts in the control mice were 10 times larger than those in the treated mice (5000 vs. 500 mm3). Our study showed that the attenuated VACV administered by the peripheral route not only is able to destroy the primary tumor, but also has a distinct antimeta­static action.
format Article
id doaj-art-291bb0831d5a4f3eac599d5224ef4a15
institution Kabale University
issn 2500-3259
language English
publishDate 2015-12-01
publisher Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
record_format Article
series Вавиловский журнал генетики и селекции
spelling doaj-art-291bb0831d5a4f3eac599d5224ef4a152025-02-01T09:58:02ZengSiberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and BreedersВавиловский журнал генетики и селекции2500-32592015-12-0119448048610.18699/VJ15.064397A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virusG. V. Kochneva0A. A. Grazhdantseva1G. F. Sivolobova2A. V. Tkacheva3A. N. Shvalov4A. Yu. Unusova5E. I. Ryabchikova6S. V. Netesov7The State Research Center of Virology and Biotechnology “VECTOR”, Novosibirsk region, Koltsovo, RussiaThe State Research Center of Virology and Biotechnology “VECTOR”, Novosibirsk region, Koltsovo, RussiaThe State Research Center of Virology and Biotechnology “VECTOR”, Novosibirsk region, Koltsovo, RussiaThe State Research Center of Virology and Biotechnology “VECTOR”, Novosibirsk region, Koltsovo, Russia Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, RussiaThe State Research Center of Virology and Biotechnology “VECTOR”, Novosibirsk region, Koltsovo, RussiaInstitute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, RussiaInstitute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, RussiaThe State Research Center of Virology and Biotechnology “VECTOR”, Novosibirsk region, Koltsovo, Russia Novosibirsk State University, Novosibirsk, RussiaHuman carcinoma A431 cells were subcutaneously injected into nude mice at points remote from each other. One of the two xenografts developed after­wards was used for treatment with a recombinant vaccinia virus, while another served as an artificial metastasis. We used the attenuated recombinant vaccinia virus (VACV) VVdGF-GFP2 of the L-IVP strain (GenBank accession number KP233807), with deletion of two virulence genes: the virus growth factor and thymidine kinase, with the gene for the green fluorescent protein (GFP2) inserted in an area of the latter. Treatments were performed by a single intratumoral injection of the recombinant VACV at a dose of 107 PFU/mouse. VACV was detected in cells of the artificial metastasis as early as two days following infection, and after 8 days virus concentrations were com- parable with those in the infected tumor (~109 PFU/ml). Electron microscopy revealed selective replication of the recombinant in tumor cells. Targeted accumulation of GFP2 in both tumor and metastasis was shown in the UV-images of the mice obtained using the In-vivo Multispectral Imaging System (Bruker, Germany). Complete destruction of the tumor was registered after 12 days, and that of metastasis, after 20 days post injection of VVdGF-GFP2. The destruction process was accompanied by pronounced edema and leukocyte infiltration of tumor tissue. The recombinant virus induced a significant reduction in the sizes of the tumor and metastasis: by the end of the experiment (35 days) the xenografts in the control mice were 10 times larger than those in the treated mice (5000 vs. 500 mm3). Our study showed that the attenuated VACV administered by the peripheral route not only is able to destroy the primary tumor, but also has a distinct antimeta­static action.https://vavilov.elpub.ru/jour/article/view/439recombinant vaccinia virushuman carcinoma a431xenograftsmetastasis modeloncolytic activity
spellingShingle G. V. Kochneva
A. A. Grazhdantseva
G. F. Sivolobova
A. V. Tkacheva
A. N. Shvalov
A. Yu. Unusova
E. I. Ryabchikova
S. V. Netesov
A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
Вавиловский журнал генетики и селекции
recombinant vaccinia virus
human carcinoma a431
xenografts
metastasis model
oncolytic activity
title A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
title_full A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
title_fullStr A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
title_full_unstemmed A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
title_short A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
title_sort model of the artificial metastasis of human epidermoid carcinoma a431 in nude mice for examination of the oncolytic activity of vaccinia virus
topic recombinant vaccinia virus
human carcinoma a431
xenografts
metastasis model
oncolytic activity
url https://vavilov.elpub.ru/jour/article/view/439
work_keys_str_mv AT gvkochneva amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT aagrazhdantseva amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT gfsivolobova amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT avtkacheva amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT anshvalov amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT ayuunusova amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT eiryabchikova amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT svnetesov amodeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT gvkochneva modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT aagrazhdantseva modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT gfsivolobova modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT avtkacheva modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT anshvalov modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT ayuunusova modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT eiryabchikova modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus
AT svnetesov modeloftheartificialmetastasisofhumanepidermoidcarcinomaa431innudemiceforexaminationoftheoncolyticactivityofvacciniavirus